Page 100 - product-manual
P. 100

TM/MC  TM/MC
                                          PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                                    Ocimum sanctum (Holy Basil)

                                    Folium Ocimi Sancti use is described in pharmacopoeias and in traditional systems of medicine
                                    for the treatment of arthritis, asthma, bronchitis, common cold, diabetes, fever, influenza, peptic
                                    ulcer and rheumatism (WHO, 2004b). Folium Ocimi Sancti has also been suggested to possess
                                    anticancer, antidiabetic, antifungal, antimicrobial, hepatoprotective, cardioprotective, antiemetic,
                                    antispasmodic,  analgesic,  adaptogenic  and  diaphoretic  actions.  Eugenol  (1-hydroxy-2-
                                    methoxy-4-allylbenzene), the active constituent present in Folium Ocimi Sancti has been found
                                    to  be  largely  responsible  for  the  therapeutic  potential  of  Folium  Ocimi  Sancti  (Prakash  &
                                    Gupta,  2005).  In  animal  models,  oral  administration  of    Folium  Ocimi  Sancti  and  Radix
                                    Withaniae prevented cadmium-induced peroxidation of tissues (Bharavi et al., 2010) and the
                                    combination also exhibited protection against exercise-induced oxidative stress in vital organs
                                    (Misra et al., 2009). The anti-stressor activity of Folium Ocimi Sancti is partly attributed to
                                    its antioxidant  properties (Jyoti  et al.,  2007).  Ocimumoside A  isolated  from  Folium  Ocimi
                                    Sancti  displayed  anti-stress  effects  by  normalizing  hyperglycemia,  plasma  corticosterone,
                                    plasma creatine kinase, and adrenal hypertrophy in acute stress-induced animal models (Gupta
                                    et al., 2007).


                   Toxicity for Folium Ocimi Sancti has not been documented in dogs and cats when administered orally in
                   therapeutic doses. The LD  for fixed oil of Folium Ocimi Sancti was calculated at 42.5 mL/kg of body weight
                                          50
               TOXICOLOGY  2007). The LD  of ethanol extract of Folium Ocimi Sancti in adult mice was found to 4.5 g/kg of body weight
                   and long-term use of oil at 3 mL/kg of body weight does not produce any adverse effects in rats (Singh et al.,
                                50
                   oral and 3.2 g/kg of body weight intraperitoneal (Rahman et al., 2011).

                   Equivalent toxic dose in 20 kg dog:   90 g PO of Folium Ocimi Sancti ethanol extract.
                   Equivalent toxic dose in 5 kg cat:    22.5 g PO of Folium Ocimi Sancti ethanol extract.



                      DRUG     Validated interactions studies do not exist for Folium Ocimi Sancti preparations. Clinical
             INTERACTIONS      interactions with other drugs have not been reported.



























                                                                                                Immunine -VM TM       |  9
   95   96   97   98   99   100   101   102   103   104   105